Wagdy Mohamed Eldehna

Dr. Wagdy Mohamed Eldehna

Kafrelsheikh University, Kafr ash Shaykh, Egypt
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Bioorganic Chemistry
Verified
Journal Article
Closed access
TATarfah Al-Warhi
Tarfah Al-Warhi
ASAhmed Sabt
Ahmed Sabt
Eslam B. ElkaeedEslam B. Elkaeed
Eslam B. Elkaeed
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna

14 October 2020 in Metabolites
Verified
Journal Article
Open access
PDF file
AAAndrea Angeli
Andrea Angeli
FCFabrizio Carta
Fabrizio Carta
Alessio NocentiniAlessio Nocentini
Alessio Nocentini
JWJean-Yves Winum
Jean-Yves Winum
RZRavis Zalubovskis
Ravis Zalubovskis
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
The tumor microenvironment is crucial for the growth of cancer cells, triggering particular biochemical and physiological changes, which frequently influence the outcome of anticancer therapies. The biochemical rationale behind many of these phenomena resides in the activation of transcription factors such as hypoxia-inducible factor 1 and 2 (HIF-1/2). In turn, the HIF pathway activates a number of genes including those involved in glucose metabolism, angiogenesis, and pH regulation. Several carbonic anhydrase (CA, EC 4.2.1.1) isoforms, such as CA IX and XII, actively participate in these processes and were validated as antitumor/antimetastatic drug targets. Here, we review the field of CA inhibitors (CAIs), which selectively inhibit the cancer-associated CA isoforms. Particular focus was on the identification of lead compounds and various inhibitor classes, and the measurement of CA inhibitory on-/off-target effects. In addition, the preclinical data that resulted in the identification of SLC-0111, a sulfonamide in Phase Ib/II clinical trials for the treatment of hypoxic, advanced solid tumors, are detailed.


1 January 2016 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SASahar M. Abou-Seri
Sahar M. Abou-Seri
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
MHMamdouh Moawad Ali Hassan
Mamdouh Moawad Ali Hassan
DEDalal A. Abou El Ella
Dalal A. Abou El Ella

1 December 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MAMahmoud F. Abo-Ashour
Mahmoud F. Abo-Ashour
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
RGRiham F. George
Riham F. George
MAMarwa Abdel-Aziz
Marwa Abdel-Aziz
MEMahmoud M. Elaasser
Mahmoud M. Elaasser
SASahar M. Abou-Seri
Sahar M. Abou-Seri

1 May 2021 in Bioorganic Chemistry
Verified
Journal Article
Closed access
Wagdy Mohamed EldehnaWagdy Mohamed Eldehna
Wagdy Mohamed Eldehna
MHMahmoud A. El Hassab
Mahmoud A. El Hassab
MAMahmoud F. Abo-Ashour
Mahmoud F. Abo-Ashour
TATarfah Al-Warhi
Tarfah Al-Warhi
MEMahmoud M. Elaasser
Mahmoud M. Elaasser
RERadwan El-Haggar
Radwan El-Haggar